Table 2 Positive rates of BRAFV600E genetic testing in different cytology Bethesda groups.

From: BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration

Bethesda groups

Number of nodules

Number of nodules with BRAFV600E positive

Positive rates

I

259

19

7.34%

II

1332

17

1.28%

III

506

139

27.47%

IV

73

1

1.37%

V

287

204

71.08%

VI

3012

2733

90.74%

Total

5469

3113

56.92%

Back to article page